Clopimozide

Chemical structure of Clopimozide

Clopimozide is a typical antipsychotic medication primarily used in the treatment of schizophrenia and other psychotic disorders. It belongs to the class of drugs known as diphenylbutylpiperidines, which are known for their long-acting effects in managing symptoms of psychosis.

Pharmacology

Clopimozide works by blocking dopamine receptors in the brain, particularly the D2 receptors. This action helps to reduce the symptoms of psychosis, such as hallucinations and delusions. The drug has a high affinity for dopamine receptors, which contributes to its effectiveness in treating psychotic disorders.

Indications

Clopimozide is indicated for the management of schizophrenia and other psychotic disorders. It is particularly useful in patients who require long-term treatment and have difficulty adhering to daily medication regimens due to its long half-life.

Side Effects

Common side effects of clopimozide include sedation, dry mouth, and constipation. More serious side effects can include extrapyramidal symptoms, such as tardive dyskinesia, and neuroleptic malignant syndrome. Patients on clopimozide should be monitored for these adverse effects.

Dosage and Administration

Clopimozide is typically administered orally. The dosage is individualized based on the patient's response and tolerance to the medication. It is important to start with a low dose and gradually increase it to minimize side effects.

Contraindications

Clopimozide is contraindicated in patients with known hypersensitivity to the drug or any of its components. It should also be used with caution in patients with cardiovascular disease, as it can affect heart rhythm.

Related pages

• Antipsychotic
• Schizophrenia
• Dopamine receptor antagonist